Monthly Cost Breakdown: Wegovy vs Mounjaro Dosage Comparison
Wegovy vs Mounjaro Dosage Schedule: Monthly Cost Planning
Understanding the wegovy vs mounjaro dosage progression is essential for accurate monthly budgeting throughout your weight management journey. Wegovy follows a five-stage dose escalation over 16 weeks, starting at 0.25mg weekly and increasing every four weeks until reaching the 2.4mg maintenance dose. This structured approach costs £79.99 for the initial month (0.25mg), progressing through £94.99 (0.5mg), £99.99 (1mg), and £139.99 (1.7mg) before reaching maintenance at £209.99 monthly. Mounjaro uses a different escalation pattern with four doses over 16-20 weeks, reaching higher maximum doses of 10mg or 15mg weekly.
The wegovy vs mounjaro dosage comparison reveals distinct cost profiles during escalation phases, with Wegovy providing predictable four-week dose intervals. Each Wegovy pen contains four weekly doses, making monthly cost calculation straightforward throughout the escalation period. Patients can budget approximately £614.96 for the complete 16-week Wegovy escalation phase, followed by £209.99 monthly for maintenance. Both medications require prescription-only access through clinical assessment, ensuring appropriate patient selection and ongoing monitoring throughout treatment.
Wegovy vs Mounjaro Dosage: Pricing and Bundle Value
Our wegovy vs mounjaro dosage pricing structure at EverydayMeds reflects the different escalation schedules and maintenance requirements. Wegovy single pen prices start at £79.99 (0.25mg) with code FIRST40 for new customers, whilst returning customers use code DOSE25 at checkout. The Intro Duo bundle (0.25mg & 0.5mg) costs £169.99, providing your first eight weeks of treatment with convenient single delivery. Progress through treatment with the Advance Duo (1mg & 1.7mg) at £269.99 for weeks 9-16, followed by maintenance supply options.
When comparing wegovy vs mounjaro dosage costs annually, Wegovy maintenance requires £2,519.88 yearly at the 2.4mg dose (12 pens × £209.99). The Ultimate Stability Trio provides three months of 2.4mg maintenance supply for £649.99, reducing ordering frequency whilst ensuring consistent treatment availability. Bundle options prioritise convenience and supply security rather than price reduction, with cold-chain delivery maintaining medication efficacy throughout the supply chain. Both discount codes apply at checkout, with FIRST40 for new customers and DOSE25 for returning patients ensuring competitive ongoing costs.
Clinical Evidence: Wegovy vs Mounjaro Dosage Effectiveness
The wegovy vs mounjaro dosage schedules reflect different clinical development programmes, with Wegovy's efficacy established through the STEP trial series at the 2.4mg weekly maintenance dose. In clinical trials, patients taking Wegovy alongside diet and exercise achieved approximately 15% average weight loss at 68 weeks in STEP 1, compared to 2.4% with placebo. The STEP 5 trial demonstrated sustained clinically studied weight loss at two years with continued 2.4mg dosing, supporting long-term maintenance effectiveness.
Mounjaro's clinical programme utilised different trial designs and patient populations, making direct wegovy vs mounjaro dosage comparisons challenging without head-to-head studies. Both medications work through GLP-1 receptor mechanisms, though Mounjaro additionally targets GIP receptors as a dual agonist. The structured dose escalation in both treatments aims to optimise tolerability whilst achieving therapeutic efficacy, with clinical assessment required before treatment initiation and dose progression monitoring throughout escalation phases.
Wegovy Mechanism: How GLP-1 Treatment Works
Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics natural incretin hormones produced in your intestine after eating. This mechanism works on appetite centres in your brain, reducing hunger signals and promoting earlier satiety after smaller meals. The weekly injection provides sustained hormone activity, maintaining appetite suppression throughout the seven-day dosing interval. GLP-1 receptors are also present in the stomach, slowing gastric emptying to extend feelings of fullness after eating. The dose escalation from 0.25mg to 2.4mg allows gradual tolerance development whilst optimising therapeutic benefit, with most patients reaching effective appetite suppression at maintenance dosing.
Ordering Process: Clinical Assessment to Delivery
Accessing Wegovy through EverydayMeds begins with a comprehensive three-minute online clinical assessment covering medical history, current medications, and weight management goals. Our prescribers review applications within three working days (24 hours with express service), ensuring appropriate patient selection according to MHRA licensing criteria. Wegovy is a prescription-only medicine requiring BMI ≥30 or BMI ≥27 with weight-related comorbidities, alongside commitment to reduced-calorie diet and increased physical activity. Once approved, next-day cold-chain delivery ensures temperature-controlled transport maintaining medication stability. Our GPhC-registered pharmacy (#9012878) provides ongoing prescriber support throughout your treatment journey, with dose progression guidance and side effect management as needed.
Storage and Practical Considerations
Wegovy storage requirements provide practical advantages in the wegovy vs mounjaro dosage comparison, with FlexTouch pens maintaining stability for six weeks at room temperature below 30°C once removed from refrigeration. This compares favourably to Mounjaro's 21-day room temperature limit, offering greater travel flexibility and convenience. Store unused Wegovy pens in your refrigerator at 2-8°C, removing each pen when ready for the four-week supply cycle. The pre-filled FlexTouch delivery system requires no mixing or preparation, with dose escalation clearly marked on each pen label. Each injection delivers precisely the prescribed weekly dose, with the escalation schedule clearly outlined in patient materials to ensure appropriate progression timing. Proper storage and handling maintain medication potency throughout the four-week pen lifecycle, supporting consistent therapeutic efficacy.
Wegovy vs Mounjaro Dosage: Long-term Cost Management
Long-term wegovy vs mounjaro dosage cost planning requires understanding maintenance phase requirements and potential treatment duration. Wegovy maintenance at 2.4mg weekly represents the ongoing cost commitment, with clinical evidence supporting continued effectiveness at two years in STEP 5 trials. Weight regain studies indicate patients regained approximately two-thirds of lost weight within one year of stopping treatment, emphasising weight management as a long-term commitment rather than short-term intervention. Monthly budgeting for £209.99 maintenance costs allows sustainable treatment planning, with bundle options reducing ordering frequency.
The wegovy vs mounjaro dosage cost comparison must consider individual response patterns, tolerability profiles, and prescriber recommendations based on clinical assessment. Neither medication ensures specific weight loss outcomes, with individual results varying based on adherence to reduced-calorie diet and increased physical activity requirements. EverydayMeds provides transparent ongoing pricing through the DOSE25 code for returning customers, ensuring predictable monthly costs throughout extended treatment periods without unexpected price variations or hidden fees.
Expert Prescriber Consultation and Treatment Selection
Choosing between wegovy vs mounjaro dosage schedules requires expert prescriber guidance considering your medical history, treatment goals, and practical preferences. Both medications are available through EverydayMeds with identical clinical assessment and prescriber review processes, ensuring appropriate treatment selection regardless of your final choice. Our experienced prescribers evaluate BMI criteria, comorbidity status, previous weight loss attempts, and potential drug interactions before recommending specific treatments. The structured dose escalation in both options allows treatment optimisation whilst monitoring tolerability and effectiveness throughout the initial months.
Weight management represents a chronic condition requiring ongoing medical supervision and support beyond medication prescribing. Regular prescriber contact ensures dose progression proceeds appropriately, side effects are managed effectively, and treatment goals remain realistic and achievable. Both Wegovy and Mounjaro require integration with lifestyle interventions including reduced-calorie diet and increased physical activity, with prescriber guidance supporting comprehensive treatment approaches rather than medication-only solutions.
Start your clinical assessment today with transparent pricing from £79.99 monthly, using code FIRST40 for new customers or DOSE25 for returning patients. Our GPhC-registered pharmacy (#9012878) ensures prescription-only access with expert prescriber support throughout your weight management journey, providing both Wegovy and Mounjaro options through identical assessment and delivery services.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
